Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev LtdfiledCriticalGlaxosmithkline Ip Dev Ltd
Publication of AR120095A1publicationCriticalpatent/AR120095A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente divulgación se refiere a composiciones para el tratamiento de las enfermedades mediadas por CD96 y los procedimientos conexos.The present disclosure relates to compositions for the treatment of CD96-mediated diseases and related methods.
Compounds derived from cyclic pantheines; pharmaceutical composition comprising them; and its use to increase the concentrations of acetyl-coa, for the treatment of cancer, inflammatory disease, neurodegenerative disease, multiple sclerosis, among other diseases.